Refractory Eczema of the hand

Drug	Drug Name	Drug Description
DB00523	Alitretinoin	A vitamin A derivative used to treat Kaposi's sarcoma and used off label to treat chronic hand eczema and psoriasis.

Drug	Drug Name	Target	Type
DB00523	Alitretinoin	Retinoic acid receptor alpha	target
DB00523	Alitretinoin	Retinoic acid receptor RXR-beta	target
DB00523	Alitretinoin	Retinoic acid receptor gamma	target
DB00523	Alitretinoin	Retinoic acid receptor beta	target
DB00523	Alitretinoin	Retinoic acid receptor RXR-gamma	target
DB00523	Alitretinoin	Retinoic acid receptor RXR-alpha	target
DB00523	Alitretinoin	Cellular retinoic acid-binding protein 2	carrier
DB00523	Alitretinoin	Cellular retinoic acid-binding protein 1	carrier
DB00523	Alitretinoin	P-glycoprotein 1	transporter
DB00523	Alitretinoin	Insulin-like growth factor-binding protein 3	target
DB00523	Alitretinoin	Pregnancy-specific beta-1-glycoprotein 5	target
DB00523	Alitretinoin	Cytochrome P450 26C1	target

Drug	Drug Name	Phase	Status	Count